Malaria
📧 Sign up to get email alerts when something new happens for Malaria.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-08-12FDA Approved: COARTEM — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for COARTEM (artemether and lumefantrine) from Novartis Pharmaceuticals Corporation, detailing t…
-
FDA approval · 2014-05-27FDA Approved: ATOVAQUONE AND PROGUANIL HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves a generic version of atovaquone and proguanil hydrochloride for the treatment and prevention of malaria (ANDA 202362, Mylan).
-
FDA approval · 2014-04-17FDA Approved: COARTEM — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for COARTEM (artemether and lumefantrine) from Novartis Pharmaceuticals Corporation, representing an…
-
FDA approval · 2014-03-05FDA Approved: DOXYCYCLINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' generic doxycycline (DOXYCYCLINE) under an original application.
-
FDA approval · 2014-02-25FDA Approved: PRIMAQUINE PHOSPHATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved the original application for PRIMAQUINE PHOSPHATE, a generic antimalarial manufactured by Unichem Pharmaceuticals (USA), In…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-11-18FDA Approved: COARTEM — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for COARTEM (artemether and lumefantrine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2013-07-26FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for mefloquine hydrochloride from Chartwell RX, LLC (ANDA 076175).
-
FDA approval · 2013-07-26FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for mefloquine hydrochloride, finalizing approval of a generic antima…
-
FDA approval · 2013-04-29FDA Approved: COARTEM — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for COARTEM (artemether and lumefantrine) submitted by Novartis Pharmaceuticals Corporation. This co…
-
FDA approval · 2013-04-05FDA Approved: COARTEM — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for COARTEM (artemether and lumefantrine) submitted by Novartis Pharmaceuticals Corporation. Thi…
-
FDA approval · 2013-04-03FDA Approved: COARTEM — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for COARTEM (artemether and lumefantrine) submitted by Novartis Pharmaceuticals Corporation. The app…
-
FDA approval · 2013-02-27FDA Approved: MALARONE — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for MALARONE (atovaquone and proguanil hydrochloride) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2012-09-28FDA Approved: QUININE SULFATE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved the Original Application for Quinine Sulfate from Teva Pharmaceuticals USA, Inc., marking the approval of a generic antimalaria…
-
FDA approval · 2011-09-20FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for mefloquine hydrochloride from Teva Pharmaceuticals USA, Inc., likely authorizing changes to labe…
-
FDA approval · 2011-09-02FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for a generic mefloquine hydrochloride product submitted by Chartwell RX, LLC. This action expan…
-
EMA approval · 2011-06-24European Medicines Agency recommends new malaria treatment for approval
The EMA recommends approval of a new malaria treatment, signaling potential regulatory clearance in the European Union.
-
FDA approval · 2011-01-21FDA Approved: CHLOROQUINE PHOSPHATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s chloroquine phosphate as an original application for a generic product. This marks approval of a…
-
FDA approval · 2011-01-21FDA Approved: CHLOROQUINE PHOSPHATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for chloroquine phosphate, a generic antimalarial, manufactured by Rising Pharma Holdings, Inc.
-
FDA approval · 2011-01-12FDA Approved: ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC — Original Application (Glenmark Pharmaceuticals Inc.,USA)
FDA approved Glenmark's pediatric generic combination of atovaquone and proguanil hydrochloride (ANDA) for malaria in pediatric patients.
-
FDA approval · 2010-02-17FDA Approved: COARTEM — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for COARTEM (artemether and lumefantrine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2009-11-18FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for mefloquine hydrochloride from Teva Pharmaceuticals USA, Inc. The approval relates to a labeling …
-
FDA approval · 2009-10-19FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for mefloquine hydrochloride from Chartwell RX, LLC under an ANDA, updating regulatory status fo…
-
FDA approval · 2009-06-12FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for mefloquine hydrochloride from Teva Pharmaceuticals USA, Inc. under an ANDA.
-
FDA approval · 2009-04-07FDA Approved: COARTEM — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved COARTEM, a fixed-dose combination of artemether and lumefantrine, under an Original Application by Novartis for the treatment o…
-
FDA approval · 2009-01-15FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for mefloquine hydrochloride submitted by Chartwell RX, LLC.